{"id":"https://openalex.org/W4225007582","doi":"https://doi.org/10.1016/j.biopsych.2022.02.783","title":"P546. Preclinical Characterization and Phase 1 Evaluation of the Tolerability, Pharmacokinetics, and Enzyme Occupancy of MK-8189, a Novel PDE10A Inhibitor","display_name":"P546. Preclinical Characterization and Phase 1 Evaluation of the Tolerability, Pharmacokinetics, and Enzyme Occupancy of MK-8189, a Novel PDE10A Inhibitor","publication_year":2022,"publication_date":"2022-04-28","ids":{"openalex":"https://openalex.org/W4225007582","doi":"https://doi.org/10.1016/j.biopsych.2022.02.783"},"language":"en","primary_location":{"id":"doi:10.1016/j.biopsych.2022.02.783","doi":"https://doi.org/10.1016/j.biopsych.2022.02.783","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.biopsych.2022.02.783","pdf_url":null,"source":{"id":"https://openalex.org/S205482884","display_name":"Biological Psychiatry","issn_l":"0006-3223","issn":["0006-3223","1873-2402"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological Psychiatry","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Sean Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sean Smith","raw_affiliation_strings":["Merck and Co., Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck and Co., Inc","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073747755","display_name":"Jason M. Uslaner","orcid":"https://orcid.org/0000-0002-8952-5940","observed_orcids":["https://orcid.org/0000-0002-8952-5940"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason Uslaner","raw_affiliation_strings":["Merck and Co., Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck and Co., Inc","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003115371","display_name":"Monika Kandebo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Monika Kandebo","raw_affiliation_strings":["Merck and Co., Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck and Co., Inc","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027646929","display_name":"Eric D. Hostetler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Hostetler","raw_affiliation_strings":["Merck and Co., Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck and Co., Inc","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021010428","display_name":"Izzat T. Raheem","orcid":"https://orcid.org/0000-0002-6769-8816","observed_orcids":["https://orcid.org/0000-0002-6769-8816"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Izzat Raheem","raw_affiliation_strings":["Merck and Co., Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck and Co., Inc","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042273890","display_name":"Mark E. Layton","orcid":"https://orcid.org/0000-0002-2607-0379","observed_orcids":["https://orcid.org/0000-0002-2607-0379"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Layton","raw_affiliation_strings":["Merck and Co., Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck and Co., Inc","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087373628","display_name":"Liza T. Gantert","orcid":"https://orcid.org/0000-0002-5042-8932","observed_orcids":["https://orcid.org/0000-0002-5042-8932"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liza Gantert","raw_affiliation_strings":["Merck and Co., Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck and Co., Inc","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054158601","display_name":"Kerry A. Riffel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kerry Riffel","raw_affiliation_strings":["Merck and Co., Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck and Co., Inc","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067918981","display_name":"Christopher D. Cox","orcid":"https://orcid.org/0000-0001-9986-1561","observed_orcids":["https://orcid.org/0000-0001-9986-1561"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Cox","raw_affiliation_strings":["Merck and Co., Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck and Co., Inc","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041695667","display_name":"Sauzanne G. Khalilieh","orcid":"https://orcid.org/0000-0002-8746-1832","observed_orcids":["https://orcid.org/0000-0002-8746-1832"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sauzanne Khalilieh","raw_affiliation_strings":["Merck and Co., Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck and Co., Inc","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112425516","display_name":"Inge De Lepeleire","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Inge De Lepeleire","raw_affiliation_strings":["MSD (Europe) Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MSD (Europe) Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072600244","display_name":"Guy M Bormans","orcid":"https://orcid.org/0000-0002-0335-7190","observed_orcids":["https://orcid.org/0000-0002-0335-7190"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Guy Bormans","raw_affiliation_strings":["KU Leuven"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"KU Leuven","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089482349","display_name":"Marleen Depr\u00e9","orcid":"https://orcid.org/0009-0005-1318-6574","observed_orcids":["https://orcid.org/0009-0005-1318-6574"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Marleen Depr\u00e9","raw_affiliation_strings":["Center for Clinical Pharmacology, University Hospital and KU Leuven"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Clinical Pharmacology, University Hospital and KU Leuven","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111776651","display_name":"J. N. J. M. De Hoon","orcid":"https://orcid.org/0000-0002-5215-9836","observed_orcids":["https://orcid.org/0000-0002-5215-9836"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Jan de Hoon","raw_affiliation_strings":["Center for Clinical Pharmacology, University Hospital and KU Leuven"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Clinical Pharmacology, University Hospital and KU Leuven","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081304921","display_name":"Koen Van Laere","orcid":"https://orcid.org/0000-0001-5200-7245","observed_orcids":["https://orcid.org/0000-0001-5200-7245"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Koen Van Laere","raw_affiliation_strings":["University Hospital and KU Leuven"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital and KU Leuven","institution_ids":["https://openalex.org/I99464096"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4520,"currency":"USD","value_usd":4520},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"91","issue":"9","first_page":"S309","last_page":"S310"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12434","display_name":"Phosphodiesterase function and regulation","score":0.6425999999046326,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12434","display_name":"Phosphodiesterase function and regulation","score":0.6425999999046326,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.33889999985694885,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pde10a-inhibitors","display_name":"PDE10A inhibitors","score":0.9890000224113464},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9480000138282776},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7620000243186951},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.953000009059906},{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":0.8209999799728394},{"id":"https://openalex.org/keywords/dopamine-d1-receptor","display_name":"dopamine D1 receptor","score":0.9739999771118164},{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.8399999737739563},{"id":"https://openalex.org/keywords/preclinical-characterization","display_name":"preclinical characterization","score":0.8119999766349792}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.771587610244751},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7715071439743042},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5730615854263306},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35510218143463135},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3327312171459198},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.08377242088317871}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.biopsych.2022.02.783","doi":"https://doi.org/10.1016/j.biopsych.2022.02.783","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.biopsych.2022.02.783","pdf_url":null,"source":{"id":"https://openalex.org/S205482884","display_name":"Biological Psychiatry","issn_l":"0006-3223","issn":["0006-3223","1873-2402"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological Psychiatry","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4404039142","https://openalex.org/W4293241927","https://openalex.org/W4313200523","https://openalex.org/W4315436606","https://openalex.org/W4327702544","https://openalex.org/W2000522375","https://openalex.org/W2968745302","https://openalex.org/W3108078095","https://openalex.org/W7143631780","https://openalex.org/W4255709199"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2022-04-29T00:00:00"}